Can vitamin B12 (cobalamin) deficiency cause hemolysis?

Can Vitamin B12 Deficiency Cause Hemolysis?

Yes, vitamin B12 deficiency can definitively cause hemolysis, though this occurs through ineffective erythropoiesis (intramedullary destruction) rather than peripheral red blood cell breakdown, and represents an important but often overlooked cause of hemolytic anemia that can mimic more serious conditions like thrombotic thrombocytopenic purpura (TTP).

Mechanism of Hemolysis in B12 Deficiency

Vitamin B12 deficiency causes hemolysis through a specific pathophysiologic mechanism. When B12 is lacking, DNA synthesis becomes impaired in rapidly dividing erythroblasts within the bone marrow 1. This leads to:

• Ineffective erythropoiesis: Abnormal red blood cell precursors undergo apoptosis (programmed cell death) within the bone marrow itself before reaching maturity
• Intramedullary hemolysis: Red cells are destroyed in the marrow rather than in circulation
• Laboratory markers of hemolysis: Elevated lactate dehydrogenase (LDH), indirect bilirubin, and low haptoglobin—identical to peripheral hemolysis 2, 3, 4

The guidelines confirm that vitamin B12 deficiency causes megaloblastic, macrocytic anemia 5, 6, and recent case reports demonstrate this can present with severe hemolysis, with LDH levels reaching 5480 U/L 3.

Critical Diagnostic Pitfall: Mimicking TTP

The most dangerous clinical scenario is when severe B12 deficiency mimics thrombotic microangiopathy (TMA) or TTP 4. This presentation includes:

• Microangiopathic hemolytic anemia with schistocytes on blood smear
• Thrombocytopenia (often part of pancytopenia)
• Elevated LDH and indirect bilirubin
• Organ dysfunction (renal failure, altered mental status)

The key distinguishing feature is a low or inappropriately normal reticulocyte count in B12 deficiency, whereas true TTP typically shows elevated reticulocytes as the marrow attempts to compensate 4. One case report documented a patient with a PLASMIC score of 7 (high risk for TTP) who received plasmapheresis and caplacizumab before ADAMTS13 testing returned normal, ultimately revealing severe B12 deficiency as the cause 4.

When to Suspect B12-Related Hemolysis

Test for B12 deficiency immediately when you see:

• Hemolytic markers (elevated LDH, indirect bilirubin, low haptoglobin) PLUS
• Macrocytosis (MCV >100 fL, though can be masked by concurrent iron deficiency) 7
• Low or normal reticulocyte count (paradoxical for hemolysis) 6
• Pancytopenia (anemia, leukopenia, thrombocytopenia together) 3
• Risk factors: Strict vegetarian/vegan diet, malabsorption, post-bariatric surgery, metformin use, age >60 years, autoimmune conditions 8, 9

The 2024 NICE guideline emphasizes testing when abnormal blood counts (anemia or macrocytosis) are present, particularly with unexplained fatigue or neurological symptoms 9.

Diagnostic Workup Algorithm

1. Initial labs: Complete blood count with MCV and RDW, reticulocyte count, LDH, indirect bilirubin, haptoglobin 7

2. If hemolysis suspected with macrocytosis and low reticulocytes: Check serum B12 level immediately 5

3. If B12 is low-normal but clinical suspicion high: Measure methylmalonic acid (MMA)—elevated MMA confirms tissue B12 deficiency even with borderline serum levels 8

4. Before treating: Check folate level but never give folate first—this can mask B12 deficiency and precipitate subacute combined degeneration of the spinal cord 5

5. If presentation mimics TTP: Send ADAMTS13 activity but consider B12 deficiency if reticulocyte count is low and initiate B12 replacement immediately while awaiting results 4

Treatment Protocol

For B12 deficiency with hemolysis (with or without neurological involvement):

The 2020 British Obesity and Metabolic Surgery Society guidelines provide the clearest treatment algorithm 5:

• With neurological involvement (altered mental status, sensory/motor symptoms, gait disturbance):

  • Hydroxocobalamin 1 mg intramuscularly on alternate days until no further improvement
  • Then 1 mg IM every 2 months for life
  • Seek urgent hematology and neurology consultation

• Without neurological involvement:

  • Hydroxocobalamin 1 mg IM three times weekly for 2 weeks
  • Then 1 mg IM every 2-3 months for life

Recent case reports confirm rapid resolution of hemolysis with this aggressive replacement strategy, with complete normalization of blood counts within 2 weeks 3, 4.

Clinical Outcomes

Hemolysis from B12 deficiency is completely reversible with appropriate treatment 2, 10. Case reports document:

• Resolution of hemolytic markers within days to weeks
• Normalization of pancytopenia within 2 weeks
• Improvement in neurological symptoms (though may be incomplete if delayed)
• No need for plasmapheresis, steroids, or other TMA-directed therapies

The key to preventing morbidity and mortality is early recognition that B12 deficiency can present as severe hemolysis and avoiding unnecessary treatments for presumed TTP or other microangiopathies 4, 11.

Common Pitfalls to Avoid

1. Don't dismiss B12 deficiency because hemolysis is present—this is a recognized but underappreciated presentation 10, 11

2. Don't wait for ADAMTS13 results before starting B12 replacement if clinical suspicion is high and reticulocyte count is low 4

3. Don't give folate before or without B12—this can precipitate irreversible neurological damage 5

4. Don't assume normal MCV rules out B12 deficiency—concurrent iron deficiency can mask macrocytosis 7

5. Don't use oral B12 for severe deficiency with hemolysis—parenteral replacement is required for rapid correction 5